Loading...

Neuren Pharmaceuticals Limited

NURPF•PNK
Healthcare
Biotechnology
$10.97
$0.00(0.00%)

Neuren Pharmaceuticals Limited (NURPF) Stock Overview

Explore Neuren Pharmaceuticals Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

F

Score: N/A

Key Financials

Market Cap1.4B
P/E Ratio15.58
EPS (TTM)$0.70
ROE0.49%
Fundamental Analysis

AI Price Forecasts

1 Week$8.63
1 Month$10.92
3 Months$4.93
1 Year Target$11.65

NURPF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Neuren Pharmaceuticals Limited (NURPF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 59.86, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $11.65.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 15.58 and a market capitalization of 1.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
-1.68%
3-Month Change
-1.68%
6-Month Change
-15.41%
Year-to-Date (YTD) Change
0.79%
1-Year Change
-42.89%
3-Year Change
154.33%
5-Year Change
824.85%
All-Time (Max) Change
-94.22%

Contact Information

https://www.neurenpharma.com
61 3 9092 0480
697 Burke Road, Camberwell, VIC, 3124

Company Facts

IPO DateNov 4, 2009
CountryAU
Actively Trading

Frequently Asked Questions

;